
### Table 2.2—Criteria for the diagnosis of diabetes
#### Link: [table2.2] ()

Number | Item | Link
------ | ---- | ----
tab01	| FPG ≥126 mg/dL (7.0 mmol/L). Fasting is defined as no caloric intake for at least 8 h. (OR) | [tab01] ()
tab02 | 2-h PG ≥200 mg/dL (11.1 mmol/L) during an OGTT. The test should be performed as described by the WHO, using glucose load containing the equivalent of 75 g anhydrous glucose dissolved in water. (OR) | [tab02] ()
tab03 | A1C ≥6.5% (48 mmol/mol). The test should be performed in a laboratory using a method that is NGSP certified and standardized to the DCCT assay. (OR) | [tab03] ()
tab04 | In a patient with classic symptoms of hyperglycemia or hyperglycemic crisis, a random plasma glucose ≥200 mg/dL (11.1 mmol/L). (OR) | [tab04] ()
table2.2Notes | In the absence of unequivocal hyperglycemia, results should be confirmed by repeat testing. | [table2.2Notes] ()

### Table 2.3—Criteria for testing for diabetes or prediabetes in asymptomatic adults
#### Link: [table2.3] ()

Number | Item | Link
------ | ---- | ----
tab05|Testing should be considered in overweight or obese (BMI >=25 kg/m2 or >=23 kg/m2 in Asian Americans) adults with A1C >=5.7% (39 mmol/mol), IGT, or IFG on previous testing|[tab05] ()|
tab06|Testing should be considered in overweight or obese (BMI >=25 kg/m2 or >=23 kg/m2 in Asian Americans) adults with first-degree relative with diabetes|[tab06] ()|
tab07|Testing should be considered in overweight or obese (BMI >=25 kg/m2 or >=23 kg/m2 in Asian Americans) adults with high-risk race/ethnicity (e.g., African American, Latino, Native American, Asian American, Pacific Islander)|[tab07] ()|
tab08|Testing should be considered in overweight or obese (BMI >=25 kg/m2 or >=23 kg/m2 in Asian Americans) adults with women who were diagnosed with GDM|[tab08] ()|
tab09|Testing should be considered in overweight or obese (BMI >=25 kg/m2 or >=23 kg/m2 in Asian Americans) adults with history of CVD|[tab09] ()|
tab10|Testing should be considered in overweight or obese (BMI >=25 kg/m2 or >=23 kg/m2 in Asian Americans) adults with hypertension (>=140/90 mmHg or on therapy for hypertension)|[tab10] ()|
tab11|Testing should be considered in overweight or obese (BMI >=25 kg/m2 or >=23 kg/m2 in Asian Americans) adults with HDL cholesterol level <35 mg/dL (0.90 mmol/L) and/or a triglyceride level >250 mg/dL (2.82 mmol/L)|[tab11] ()|
tab12|Testing should be considered in overweight or obese (BMI >=25 kg/m2 or >=23 kg/m2 in Asian Americans) adults with women with polycystic ovary syndrome|[tab12] ()|
tab13|Testing should be considered in overweight or obese (BMI >=25 kg/m2 or >=23 kg/m2 in Asian Americans) adults with physical inactivity|[tab13] ()|
tab14|Testing should be considered in overweight or obese (BMI >=25 kg/m2 or >=23 kg/m2 in Asian Americans) adults with other clinical conditions associated with insulin resistance (e.g., severe obesity, acanthosis nigricans).|[tab14] ()|
tab15|For all patients, testing should begin at age 45 years|[tab15] ()|
tab16|If results are normal, testing should be repeated at a minimum of 3-year intervals, with consideration of more frequent testing depending on initial results (e.g., those with prediabetes should be tested yearly) and risk status.|[tab16] ()|

### Table 2.4—Categories of increased risk for diabetes (prediabetes)
#### Link: [table2.4] ()

Number | Item | Link
------ | ---- | ----
tab17 | FPG 100 mg/dL (5.6 mmol/L) to 125 mg/dL (6.9 mmol/L) (OR) | [tab17]()
tab18 | 2-h PG in the 75-g OGTT 140 mg/dL (7.8 mmol/L) to 199 mg/dL (11.0 mmol/L) (OR) | [tab18]()
tab19 | A1C 5.7-6.4% (39247 mmol/mol) (OR) |[tab19] ()
table2.4Notes | For all three tests, risk is continuous, extending below the lower limit of the range and becoming disproportionately greater at the higher end of the range. |[table2.4Notes] ()

### Table 2.5—Testing for type 2 diabetes or prediabetes in asymptomatic children
#### Link: [table2.5] ()

Number | Item | Link
------ | ---- | ----
|

### Table 3.2—Referrals for initial care management
#### Link: [table3.2] ()

Number | Item | Link
------ | ---- | ----
|

### Table 4.1—MNT recommendations
#### Link: [table4.1] ()

Number | Item | Link
------ | ---- | ----
|

### Table 10.2—Management of CKD in diabetes
#### Link: [table10.2] ()

Number | Item | Link
------ | ---- | ----
|
